Use of serum VEGF (SVEGF) levels to predict outcome of esophageal cancer (EC) patients undergoing preoperative chemoradiation (CRT)

被引:1
|
作者
De Vita, F. [1 ]
机构
[1] Univ Naples 2, Div Med Oncol, Naples, Italy
关键词
D O I
10.1200/jco.2010.28.15_suppl.4140
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4140
引用
下载
收藏
页数:1
相关论文
共 50 条
  • [31] Does fall in serum glutathione predict the long-term outcome to concurrent chemoradiation for cervical cancer patients?
    Narasappa, Manjunath Gudibande
    Gururajacharl, Janaki Manur
    Chokkanna, Vasudha Kambam
    Somashekar, Mohankumar
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (03) : 1167 - 1171
  • [32] Influence of Serum VEGF Levels on Therapeutic Outcome and Diagnosis/Prognostic Value in Patients with Cervical Cancer
    Du, Ke
    Gong, Hong-Ying
    Gong, Zhi-Min
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (20) : 8793 - 8796
  • [33] Increased circulating levels of VEGF-C to predict outcome in resectable gastric cancer patients.
    De Vita, Fernando
    Orditura, Michele
    Laterza, Maria Maddalena
    Fabozzi, Alessio
    Ventriglia, Jole
    Savastano, Beatrice
    Petrillo, Angelica
    Giordano, Guido
    Gambardella, Valentina
    Martinelli, Erika
    Ciardiello, Fortunato
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [34] Therapy-induced expression of NF-κB portends poor prognosis in patients with localized esophageal cancer undergoing preoperative chemoradiation
    Izzo, J. G.
    Wu, X.
    Wu, T. -T.
    Huang, P.
    Lee, J. -S.
    Liao, Z.
    Lee, J. H.
    Bhutani, M. S.
    Hofstetter, W.
    Maru, D.
    Hung, M. -C.
    Ajani, J. A.
    DISEASES OF THE ESOPHAGUS, 2009, 22 (02): : 127 - 132
  • [35] Incidental Use of Beta-Blockers, Serum VEGF, and Their Association With Disease Outcome in Patients with NoneSmall-Cell Lung Cancer Treated with Definitive Chemoradiation Therapy
    Xu, T.
    Xu, Y.
    Huo, J.
    Yang, P.
    Gomez, D. R.
    Liao, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (01): : 245 - 245
  • [36] Serum VEGF levels in patients undergoing primary radiotherapy for cervical cancer:: impact on progression-free survival
    Bachtiary, B
    Selzer, E
    Knocke, TH
    Pötter, R
    Obermair, A
    CANCER LETTERS, 2002, 179 (02) : 197 - 203
  • [37] USE OF MOLECULAR IMAGING TO PREDICT CLINICAL OUTCOME IN PATIENTS WITH RECTAL CANCER AFTER PREOPERATIVE CHEMOTHERAPY AND RADIATION
    Konski, Andre
    Li, Tianyu
    Sigurdson, Elin
    Cohen, Steven J.
    Small, William, Jr.
    Spies, Stewart
    Yu, Jian Q.
    Wahl, Andrew
    Stryker, Steven
    Meropol, Neal J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (01): : 55 - 59
  • [38] Prognostic Role of Preoperative Serum Lipid Levels in Patients Undergoing Radical Prostatectomy for Clinically Localized Prostate Cancer
    Wettstein, Marian S.
    Saba, Karim
    Umbehr, Martin H.
    Murtola, Teemu J.
    Fankhauser, Christian D.
    Adank, Jean-Pascal
    Hofmann, Marc
    Sulser, Tullio
    Hermanns, Thomas
    Moch, Holger
    Wild, Peter
    Poyet, Cedric
    PROSTATE, 2017, 77 (05): : 549 - 556
  • [39] A phase II trial of preoperative one cycle of induction chemotherapy [capecitibine (CAP), CDDP] followed by concurrent chemoradiation (CRT) in patients (pts) with resectable esophageal cancer.
    Kim, SB
    Park, SI
    Kim, JH
    Jung, HY
    Lee, GH
    Park, JH
    Ahn, JH
    Cho, KJ
    Song, HY
    Min, YI
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 323S - 323S
  • [40] Effect of thalidomide combined with TP chemotherapy on serum VEGF and NRP-1 levels advanced esophageal cancer patients
    Zheng, Wenhong
    Fu, Lijuan
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (09): : 10809 - 10815